Research group:
Immunopathology and translational research in respiratory diseases
Contact Information
Department of Cell Biology, Physiology and Immunology
cruz(a)ub.edu
Academic Training
Inmunologia Avanzada
. Universidad de Barcelona - Universidad Autonoma de Barcelona
. 01/09/2012
. (Official Master)Biotecnologia
. Universitat de Lleida
. 30/06/2011
. (Diploma / Degree / Activities)Characterization of the pulmonary and systemic immune response in relation with lung stem cells in patients with COPD
. Fundació Clinic per la Recerca Biomedica - IDIBAPS
. 21/07/2017
. (Ph.D.)
Research interests
Early Identification and Personalized Treatment of Pulmonary Fibrosis in Interstitial Lung DiseasesEx vivo lung fibrosis model as a platform to investigate immune-fibrosis interactionsCharacterization of the aging and immunological effect on the stage pulmonary fibrosis patients
Projects
Doctorat industrial en col.laboració amb empresa: Loop Diagnostics,S.L
.
2025 - 2028
. Ref.2025DI00060
. Agència de Gestió d'Ajuts Universitaris i de Recerca (AGAUR)
. PI: Tamara Cruz Santa CruzDesentrañando las alteraciones en la respuesta a la terapia antifibrótica
.
2025 - 2027
. Separ
. PI: Tamara Cruz Santa CruzIdentifying new biomarkers for progressive pulmonary fibrosis and response to therapy, moving towards precision medicine: the FIBROPROG study.
.
2024 - 2026
. Ref.PI23/00924
. Instituto de Salud Carlos III
. PI: Tamara Cruz Santa Cruz y Jacobo SellaresFrom COPD Heterogeneity to Personalized Medicine (COPD HOPE)
.
2022 - 2025
. Ref.ID 100010434, LCF/BQ/PI22/11910042
. La Caixa
. PI: Tamara Cruz Santa CruzReveling the molecular mechanisms of progressive pulmonary fibrosis.
.
2024 - 2026
. Separ
. PI: Tamara Cruz Santa Cruz y Fernanda Hernandez
Journal Publications
Hernandez-Gonzalez, F.; Pietrocola, F.; Cameli, P.; Bargagli, E.; Prieto-González, S.; Cruz, T.; Mendoza, N.; Rojas, M.; Serrano, M.; Agustí, A.; Faner, R.; Gómez-Puerta, J.A.; Sellares, J.(2024).
Exploring the Interplay between Cellular Senescence, Immunity, and Fibrosing Interstitial Lung Diseases: Challenges and Opportunities.International Journal of Molecular Sciences, 25(14)
. https://doi.org/10.3390/ijms25147554. ISSN: 1661-6596Tamara Cruz, Paula A Agudelo Garcia, Julián A Chamucero-Millares, Anna Bondonese, Nilay Mitash, John Sembrat, Tracy Tabib, Wenping Zhang, Nouraie Seyed, Victor Peters, Sean Stacey, Dario Vignali, Ana L Mora, Robert Lafyatis, Mauricio Rojas(2023).
End-Stage Idiopathic Pulmonary Fibrosis Lung Microenvironment Promotes Impaired NK Activity.The Journal of Immunology
. https://doi.org/10.4049/jimmunol.2300182. ISSN: 0022-1767Cruz, T.; Mendoza, N.; Casas-Recasens, S.; Noell, G.; Hernandez-Gonzalez, F.; Frino-Garcia, A.; Alsina-Restoy, X.; Molina, M.; Rojas, M.; Agustí, A.; Sellares, J.; Faner, R.(2023).
Lung immune signatures define two groups of end-stage IPF patients.Respiratory Research, 24(1), p. 236
. https://doi.org/10.1186/s12931-023-02546-8. ISSN: 1465-993XEarly events marking lung fibroblast transition to profibrotic state in idiopathic pulmonary fibrosis(2023).
Minxue Jia, Lorena Rosas, Maria G. Kapetanaki, Tracy Tabib, John Sebrat, Tamara Cruz, Anna Bondonese, Ana L. Mora, Robert Lafyatis, Mauricio Rojas and Panayiotis V. Benos.Respiratory Research
. https://doi.org/10.1186/s12931-023-02419-0. ISSN: 1465-9921Tamara Cruz, Minxue Jia, John Sembrat, Tracy Tabib, Naomi Agostino, Tullia C. Bruno, Dario Vignali, Pablo Sanchez, Robert Lafyatis, Ana L. Mora, Panayiotis Benos and Mauricio RojasMauricio Rojas(2021).
Reduced Proportion and Activity of Natural Killer Cells in the Lung of Patients with Idiopathic Pulmonary Fibrosis.American Journal of Respiratory and Critical Care Medicine
. https://doi.org/10.1164/rccm.202012-4418LE. ISSN: 1073-449X